Quick recap The meeting focused on the recent media hysteria surrounding Kratom, particularly the misrepresentation of synthetic products as natural Kratom in news reports. Christopher expressed frustration with the media's lack of distinction between natural Kratom and synthetic substances, which has led to public confusion and fear. The group discussed the need for regulation and education to differentiate between safe, natural Kratom and dangerous synthetic products. They shared strategies for engaging with media and policymakers, emphasizing the importance of personal stories and humanizing the Kratom community. The conversation also touched on the challenges posed by bad actors in the industry, the role of politics in the current situation, and the potential impact of upcoming elections on Kratom policy. Participants shared personal experiences and advocacy efforts, highlighting the need for a national conversation about the benefits and risks of Kratom. Summary Kratom Media Coverage Concerns Christopher expressed frustration over recent media coverage of Kratom, noting that news stations across the country are incorrectly discussing synthetic Kratom products without waiting for toxicology results. He attributed the media focus partly to upcoming midterm elections and suggested that officials like Sarah Carter are contributing to the confusion by discussing Kratom without distinguishing between natural and synthetic forms. Christopher mentioned reaching out to multiple news stations daily to correct the narrative and noted that even his family members have contacted him seeking clarification about the media reports. Kratom Overdose Case Discussion The group discussed a recent overdose case involving synthetic Kratom pills, with Christopher expressing skepticism about media coverage and speculation surrounding the incident. Michael suggested the substance might be MGM-16, a potent synthetic opioid, while Drew noted that toxic screening results would be needed to confirm the substance's identity. The discussion highlighted concerns about regulatory approaches to Kratom, with Christopher arguing that proper regulation should have been implemented years ago rather than banning products, which would likely lead to underground sales of potentially more dangerous substances.